CING: 81.5% – Cingulate Announces Positive Top-Line Results from Phase 3 Adult Efficacy and Safety Trial of CTx-1301 (dexmethylphenidate) for ADHD
DFLI: 45.8% – Dragonfly Energy Partners with World’s Largest Teardrop Manufacturer to Provide Full Lithium Power Systems
BTTX: 24.5% – Better Therapeutics shares are trading higher after the FDA approved the company’s AspyreRx prescription-only digital therapeutic treatment to provide cognitive behavioral therapy to adult patients with type 2 diabetes.
